4,4'-(1,4-phenylene)bis(3-cyano-1,2,5-oxadiazole 2-oxide) | 1147335-91-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 4,4'-(1,4-phenylene)bis(3-cyano-1,2,5-oxadiazole 2-oxide)
• 英文别名: 4,4'-(1,4-phenyIene)bis(3-cyano-1,2,5-oxadiazoIe-2-oxide)；4,4''-(1,4-Phenylene)bis(3-cyano-1,2,5-oxadiazole 2-oxide)；4-[4-(4-cyano-5-oxido-1,2,5-oxadiazol-5-ium-3-yl)phenyl]-2-oxido-1,2,5-oxadiazol-2-ium-3-carbonitrile
• CAS: 1147335-91-8
• 化学式: C₁₂H₄N₆O₄
• 分子量: 296.202
• InChiKey: PWMRBIOVMKULOQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  22
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  151
• 氢给体数：
  0
• 氢受体数：
  8

反应信息

• 作为产物：
  描述：

  在 氯化亚砜 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 4,4'-(1,4-phenylene)bis(3-cyano-1,2,5-oxadiazole 2-oxide)
  参考文献：
  名称：

  Synthesis of oxadiazole-2-oxide analogues as potential antischistosomal agents

  摘要：

  The synthesis of several 1,2,5-oxadiazole-2-oxide (Furoxan) analogues is described herein. These compounds were prepared in an effort to probe the SAR around the phenyl substituent and oxadiazole core for our studies toward thioredoxin-glutathione reductase (TGR) inhibition and antischistosomal activity. Published by Elsevier Ltd.

  DOI：

  10.1016/j.tetlet.2009.01.120

文献信息

• OXADIAZOLE-2-OXIDES AS ANTISCHISTOSOMAL AGENTS
  申请人：Thomas Craig J.

  公开号：US20110207784A1

  公开（公告）日：2011-08-25

  The invention provides 1,2,5-oxadiazole-containing compounds of Formula (I), wherein R 1 , A, and R 2 are as defined herein, that are useful in treating schistosomiasis. The invention also provides a composition comprising a pharmaceutically suitable carrier and at least one compound of the invention, and a method of treating schistosomiasis in a mammal.

  该发明提供了公式（I）中含有1,2,5-噁二唑基团的化合物，其中R1、A和R2如本文所定义，可用于治疗血吸虫病。该发明还提供了一种包含药学适用载体和至少一种该发明化合物的组合物，以及一种治疗哺乳动物血吸虫病的方法。
• [EN] OXADIAZOLE-2-OXIDES AS ANTISCHISTOSOMAL AGENTS<br/>[FR] OXADIAZOLE-2-OXYDES EN TANT QU'AGENTS ANTISCHISTOSOMIAUX
  申请人：US HEALTH

  公开号：WO2010019772A2

  公开（公告）日：2010-02-18

  The invention provides 1,2,5-oxadiazole-containing compounds of Formula (I), wherein R1, A, and R2 are as defined herein, that are useful in treating schistosomiasis. The invention also provides a composition comprising a pharmaceutically suitable carrier and at least one compound of the invention, and a method of of treating schistosomiasis in a mammal.